Hemostemix Inc.

News & Events

Press Releases

In The Media

1. Hemostemix Presents at TERMIS 2025, Freiburg, Germany

   Newsfile MAY 20, 2025 9:00 AM EDT
   Freiburg, Germany--(Newsfile Corp. - May 20, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF), ...
   READ ARTICLE

2. Hemostemix Closes Private Placement of USD $336,500 at $0.295 per Share

   Newsfile MAY 12, 2025 9:00 AM EDT
   Calgary, Alberta--(Newsfile Corp. - May 12, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (F...
   READ ARTICLE

3. Hemostemix at Invest Stuttgart

   Newsfile MAY 8, 2025 9:12 AM EDT
   Calgary, Alberta--(Newsfile Corp. - May 8, 2025) -  Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTX...
   READ ARTICLE

4. Hemostemix Engages PatentVest to Strengthen its Global Patent Portfolio

   Newsfile APR 23, 2025 11:53 AM EDT
   Calgary, Alberta--(Newsfile Corp. - April 23, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ...
   READ ARTICLE

5. Hemostemix's Pitch to Wall Street: ACP-01 Vascular Dementia Trial will Generate $5,365,000, Capture Data, as a Phase 1 Clinical Trial

   Newsfile MAR 17, 2025 10:28 AM EDT
   Calgary, Alberta--(Newsfile Corp. - March 17, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ...
   READ ARTICLE

6. Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing

   GlobeNewswire MAR 14, 2025 8:35 AM EDT
   NEW YORK, March 14, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietar...
   READ ARTICLE

7. Life Sciences Investor Forum Agenda Announced for March 13th

   GlobeNewswire MAR 12, 2025 1:12 PM EDT
   NEW YORK, March 12, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietar...
   READ ARTICLE

8. Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01

   Newsfile MAR 6, 2025 7:30 AM EST
   A growing body of clinical evidence supports the use of Firefly's FDA-Cleared BNA(TM) platform to...
   READ ARTICLE

9. Hemostemix Sells Its 23rd ACP-01 Therapy Convertible Debenture

   Newsfile MAR 5, 2025 7:45 AM EST
   Calgary, Alberta--(Newsfile Corp. - March 5, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (...
   READ ARTICLE

10. RETRANSMISSION: Hemostemix Licenses CytoImmune's BioReactor Technologies

    Newsfile FEB 20, 2025 6:05 AM EST
    Calgary, Alberta--(Newsfile Corp. - February 20, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTX...
    READ ARTICLE